22 mayo 2015
New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/3qCNErFpODc/150522141324.htm
